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The National Institutes of 
Health (NIH) has awarded 
Maine Medical Center’s re-
search institute and its part-
nering institution, the Uni-
versity of Vermont (UVM), 
a $339,000 grant to study 
the impact that stricter opi-
oid prescribing laws have 
had on population health in 
northern New England. 
The research will be done 
through the Northern New 
England Clinical and Trans-
lational Research Network 
(NNE-CTR), comprised of 
researchers from the Maine 
Medical Center Research 
Institute (MMCRI) and 
UVM, and funded by the 
NIH. 
In 2016, Maine and Ver-
mont responded to the opi-
oid crisis with legislation 
instituting stricter opioid 
prescribing guidelines and 
requirements for prescrip-
tion drug monitoring pro-
grams. The goal was to re-
duce access to prescription 
opioids and make it more 
difficult for patients to ob-
tain prescriptions from mul-
tiple providers. Investiga-
tors Kathleen Fairfield, 
MD, DrPH, of MMCRI and 
the Department of Medi-
cine at Maine Medical  
Center, and Valerie Harder, 
PhD, MHS, and Timothy 
Plante, MD, MHS, of UVM 
will analyze whether that 
legislation has successfully 
led to a decrease in opioid-
related overdoses, hospitali-
zations and other medical 
events and whether there 
were unintended conse-
quences, such as patients 
suffering from substance 
use disorders turning in-
stead to the illegal use of 
heroin. The team also will 
analyze whether outcomes 
are different for various pa-
tient demographics, such as 
whether they live in a rural 
or urban area. 
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LEFT: MMC’s Hospital Emergency Response Team (HERT) 
triages actors portraying patients in a preparedness training exercise 
simulating a mass casualty event following a hypothetical chemical 
spill at a local manufacturing facility. 
 
BELOW: Members of MMC’s Hospital Incident Command  
System team coordinate the response to the mock mass casualty event 
during last Thursday’s training drill. 
Maine Medical Center has 
been designated an Aetna 
Institute of Quality® (IOQ) 
Cardiac Care Facility for 
Cardiac Medical Interven-
tion, Cardiac Rhythm and 
Cardiac Surgery Programs. 
IOQ-designated Cardiac 
Care Facilities meet evi-
dence-based and recognized 
standards for clinical out-
comes, processes of care 
and patient safety, accord-
ing to Aetna. Factors 
weighed in designating the 
IOQ facilities include Board 
certification, participation in 
quality improvement sur-
veys and low mortality, 
morbidity and readmission 
rates, among other criteria. 
IOQ Cardiac Care Facilities 
also need to meet cost-
efficiency standards. 
“This designation validates 
Maine Medical Center’s 
continuous commitment to 
quality patient care. It is a 
testament to the dedication 
of our physicians and staff,” 
said Douglas B. Sawyer, 
MD, Chief Cardiovascular 
Services and Physician Lead 
for Maine Medical Center 
Cardiovascular Service Line.  
Aetna makes information 
about the quality and cost 
of health care services avail-
able to its members to help 
them make informed deci-





“This research provides us 
the opportunity to study the 
impact of state laws regard-
ing opioid prescribing while 
engaging with a wide variety 
of community members in 
real time,” said Dr. Fair-
field. “We hope this work 
will help inform clinical care 
of patients, community-
based interventions, future 
policy changes and addi-
tional research.” 
The NIH awarded MMC 
and UVM a $20 million re-
search grant in 2017 to es-
tablish the NNE-CTR, a 
regional network that would 
help researchers develop 
and implement innovative 
medical treatments for 
many chronic diseases prev-
alent in our region including 
cancer, heart disease, obesi-
ty, diabetes, Alzheimer’s 
disease and substance 
abuse. Research activities 
also focus on defining opti-
mal methods of prevention 
and health care delivery in 
rural environments, where 
approximately 60 percent of 
Maine’s population re-
sides.  This grant provides 
additional funds for the 
NNE-CTR to focus specifi-
cally on the impact of the 
opioid crisis on this  
community. 
“There is confidence the 
program will provide op-
tions and opportunities for 
development of a blueprint 
to address opioid overdose, 
with the potential to have a 
powerful influence on ad-
dressing addiction in north-
ern New England,” said 
Clifford Rosen, MD, Direc-
tor of the Center for Clini-
cal and Translational Re-
search at MMCRI and Prin-
cipal Investigator, NNE-
CTR. “The $339,000 grant 
leverages the research infra-
structure of the NNE-CTR 
and will reinforce its reach 
in a high-priority medical 
challenge for our region and 
beyond.” 
“A decisive strength of the 
program is our collabora-
tion with colleagues at the 
Maine Medical Center Re-
search Institute,” said Gary 
Stein, PhD, Principal Inves-
tigator, NNE-CTR and Di-
rector of the University of 
Vermont Cancer Center. 
“This new initiative 
launched on September 
1.  The complementary in-
stitutional expertise will 
have an impact locally, re-
gionally and beyond.”  
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